| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2023 |
4
| PATTERSON LEONE D (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 22,500 options to buy
@ $4.86, valued at
$109.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| PATTERSON LEONE D (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.46, valued at
$34.6k
|
|
| 02/17/2022 |
4
| PATTERSON LEONE D (Chief Fin. and Bus. Officer) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 66,000 options to buy
@ $15.19, valued at
$1M
|
|
| 08/09/2021 |
3
| PATTERSON LEONE D (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| PATTERSON LEONE D (President and CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 12,471 shares
@ $14.1, valued at
$175.8k
Sold 62 shares
@ $14.1393, valued at
$876.6 |
|
| 07/13/2020 |
4
| PATTERSON LEONE D (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 10,700 options to buy
@ $18, valued at
$192.6k
Granted 18,300 options to buy
@ $18, valued at
$329.4k
|
|
| 07/09/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/17/2020 |
4
| PATTERSON LEONE D (President) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 13,171 shares
@ $24.68, valued at
$325.1k
|
|
| 05/08/2020 |
4
| PATTERSON LEONE D (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 20,000 shares
@ $20.02, valued at
$400.4k
Exercised 20,000 options to buy
@ $3.44, valued at
$68.8k
|
|
| 05/08/2020 |
4/A
| PATTERSON LEONE D (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Paid exercise price by delivering 10,985 shares
@ $10.24, valued at
$112.5k
|
|
| 03/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2018 |
4
| PATTERSON LEONE D (President, CEO and CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 150,000 options to buy
@ $4.7, valued at
$705k
|
|
| 06/18/2018 |
4
| PATTERSON LEONE D (SVP, CFO, Interim Pres and CEO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 88,496 shares
@ $0 |
|
| 02/20/2018 |
4
| PATTERSON LEONE D (CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 160,000 options to buy
@ $6.4, valued at
$1M
|
|
| 02/13/2017 |
4
| PATTERSON LEONE D (CFO) has filed a Form 4 on Adverum Biotechnologies, Inc. |
| 06/16/2016 |
4
| PATTERSON LEONE D (CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $3.44, valued at
$688k
|
|
| 06/16/2016 |
3
| PATTERSON LEONE D (CFO) has filed a Form 3 on Adverum Biotechnologies, Inc. |
| 03/24/2015 |
4
| PATTERSON LEONE D (CFO) has filed a Form 4 on diaDexus, Inc.|
Txns:
| Granted 700,000 options to buy
@ $0.37, valued at
$259k
|
|
| 10/30/2014 |
4
| PATTERSON LEONE D (Vice President, CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Granted 4,161 shares
@ $21.588, valued at
$89.8k
Disposed/sold 7,500 options to buy
@ $0
Disposed/sold 6,666 options to buy
@ $0
Disposed/sold 9,583 options to buy
@ $0 |
|
| 06/05/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/08/2013 |
4
| PATTERSON LEONE D (Vice President, CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Granted 80,000 options to buy
@ $5.4, valued at
$432k
|
|
|